Skip to main navigation Skip to search Skip to main content

Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: A KASID prospective multicenter cohort study

  • Seung Yong Shin
  • , Soo Jung Park
  • , Young Kim
  • , Jong Pil Im
  • , Hyo Jong Kim
  • , Kang Moon Lee
  • , Ji Won Kim
  • , Sung Ae Jung
  • , Jun Lee
  • , Sang Bum Kang
  • , Sung Jae Shin
  • , Eun Sun Kim
  • , You Sun Kim
  • , Tae Oh Kim
  • , Hyun Soo Kim
  • , Dong Il Park
  • , Hyung Kil Kim
  • , Eun Soo Kim
  • , Young Ho Kim
  • , Do Hyun Kim
    • Dennis Teng, Jong Hwa Kim, Wonyong Kim, Chang Hwan Choi, behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
  • Chung-Ang University
  • Yonsei University
  • Seoul National University
  • Kyung Hee University
  • The Catholic University of Korea
  • SMG-SNU Boramae Medical Center
  • Ewha Womans University
  • Chosun University
  • Ajou University
  • Korea University
  • Inje University
  • Chonnam National University
  • Kangbuk Samsung Hospital
  • Inha University
  • Sungkyunkwan University
  • AbbVie

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: A KASID prospective multicenter cohort study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry